| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1176 | 16 | 835 | 116 | 1412 | 221 | 1345 |
| ERLYTX | 78 | 2 | 104 | 7 | 85 | 18 | 110 |
| GI | 183 | 3 | 157 | 18 | 219 | 32 | 195 |
| GU | 355 | 6 | 313 | 26 | 317 | 44 | 268 |
| LEUK | 151 | 4 | 209 | 17 | 207 | 33 | 201 |
| LUNG | 191 | 4 | 209 | 12 | 146 | 31 | 189 |
| LYMPH | 412 | 8 | 417 | 49 | 597 | 94 | 572 |
| MELAN | 126 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 113 | 4 | 209 | 9 | 110 | 26 | 158 |
| MMYL | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| MULT | 40 | 0 | 0 | 4 | 49 | 13 | 79 |
| OTHER | 55 | 2 | 104 | 4 | 49 | 11 | 67 |
| SXQOL | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2882 | 49 | 2557 | 263 | 3203 | 524 | 3190 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 24 | 2 | 12 | |
| CCD | 162 | 2 | 104 | 19 | 231 | 38 | 231 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 3 | 18 |
| GU | 3 | 0 | 0 | 0 | 0 | 2 | 12 |
| LEUK | 626 | 7 | 365 | 52 | 633 | 107 | 651 |
| LUNG | 364 | 6 | 313 | 24 | 292 | 61 | 371 |
| OTHER | 33 | 0 | 0 | 2 | 24 | 4 | 24 |
| PEOLC | 107 | 0 | 0 | 1 | 12 | 2 | 12 |
| PREV | 225 | 5 | 261 | 22 | 268 | 46 | 280 |
| SXQOL | 612 | 9 | 470 | 64 | 779 | 124 | 755 |
| Total | 2144 | 29 | 1513 | 186 | 2263 | 389 | 2366 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 24 | 2 | 12 | |
| BREAST | 1176 | 16 | 835 | 116 | 1412 | 221 | 1345 |
| CCD | 162 | 2 | 104 | 19 | 231 | 38 | 231 |
| ERLYTX | 88 | 2 | 104 | 7 | 85 | 21 | 128 |
| GI | 183 | 3 | 157 | 18 | 219 | 32 | 195 |
| GU | 358 | 6 | 313 | 26 | 317 | 46 | 280 |
| LEUK | 777 | 11 | 574 | 69 | 840 | 140 | 852 |
| LUNG | 555 | 10 | 522 | 36 | 438 | 92 | 560 |
| LYMPH | 412 | 8 | 417 | 49 | 597 | 94 | 572 |
| MELAN | 126 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 113 | 4 | 209 | 9 | 110 | 26 | 158 |
| MMYL | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| MULT | 40 | 0 | 0 | 4 | 49 | 13 | 79 |
| OTHER | 88 | 2 | 104 | 6 | 73 | 15 | 91 |
| PEOLC | 107 | 0 | 0 | 1 | 12 | 2 | 12 |
| PREV | 225 | 5 | 261 | 22 | 268 | 46 | 280 |
| SXQOL | 613 | 9 | 470 | 64 | 779 | 124 | 755 |
| Total | 5026 | 78 | 4070 | 449 | 5466 | 913 | 5556 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 745 | 9 | 470 | 73 | 889 | 133 | 810 |
| ERLYTX | 48 | 2 | 104 | 7 | 85 | 16 | 97 |
| GI | 131 | 1 | 52 | 12 | 146 | 24 | 146 |
| GU | 282 | 3 | 157 | 22 | 268 | 33 | 201 |
| LEUK | 95 | 1 | 52 | 9 | 110 | 19 | 116 |
| LUNG | 121 | 4 | 209 | 11 | 134 | 21 | 128 |
| LYMPH | 272 | 7 | 365 | 32 | 390 | 58 | 353 |
| MELAN | 85 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 66 | 2 | 104 | 2 | 24 | 13 | 79 |
| MMYL | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| MULT | 15 | 0 | 0 | 0 | 0 | 5 | 30 |
| OTHER | 55 | 2 | 104 | 4 | 49 | 11 | 67 |
| SXQOL | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1917 | 31 | 1617 | 173 | 2107 | 334 | 2033 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 2 | 24 | 2 | 12 | |
| CCD | 132 | 2 | 104 | 13 | 158 | 25 | 152 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 3 | 18 |
| GU | 3 | 0 | 0 | 0 | 0 | 2 | 12 |
| LEUK | 268 | 3 | 157 | 19 | 231 | 42 | 256 |
| LUNG | 228 | 5 | 261 | 17 | 207 | 36 | 219 |
| OTHER | 33 | 0 | 0 | 2 | 24 | 4 | 24 |
| PEOLC | 78 | 0 | 0 | 1 | 12 | 2 | 12 |
| PREV | 224 | 4 | 209 | 21 | 256 | 45 | 274 |
| SXQOL | 442 | 6 | 313 | 48 | 584 | 91 | 554 |
| Total | 1420 | 20 | 1044 | 123 | 1496 | 252 | 1533 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1 | 12 | 1 | 6 | |
| BREAST | 923 | 10 | 522 | 87 | 1059 | 163 | 992 |
| CCD | 165 | 2 | 104 | 17 | 207 | 36 | 219 |
| ERLYTX | 58 | 2 | 104 | 7 | 85 | 19 | 116 |
| GI | 135 | 2 | 104 | 10 | 122 | 25 | 152 |
| GU | 316 | 5 | 261 | 23 | 280 | 45 | 274 |
| LEUK | 364 | 4 | 209 | 28 | 341 | 61 | 371 |
| LUNG | 369 | 10 | 522 | 32 | 390 | 67 | 408 |
| LYMPH | 272 | 7 | 365 | 32 | 390 | 58 | 353 |
| MELAN | 85 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 66 | 2 | 104 | 2 | 24 | 13 | 79 |
| MMYL | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| MULT | 39 | 2 | 104 | 3 | 37 | 5 | 30 |
| OTHER | 217 | 2 | 104 | 6 | 73 | 19 | 116 |
| PEOLC | 76 | 1 | 52 | 2 | 24 | 2 | 12 |
| PREV | 224 | 4 | 209 | 21 | 256 | 45 | 274 |
| SXQOL | 443 | 6 | 313 | 48 | 584 | 91 | 554 |
| Total | 3754 | 59 | 3077 | 320 | 3896 | 651 | 3962 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 982 | 15 | 783 | 96 | 1169 | 193 | 1175 |
| ERLYTX | 73 | 2 | 104 | 7 | 85 | 15 | 91 |
| GI | 108 | 2 | 104 | 11 | 134 | 18 | 110 |
| GU | 234 | 5 | 261 | 21 | 256 | 37 | 225 |
| LEUK | 118 | 4 | 209 | 16 | 195 | 28 | 170 |
| LUNG | 162 | 3 | 157 | 10 | 122 | 29 | 177 |
| LYMPH | 342 | 7 | 365 | 44 | 536 | 82 | 499 |
| MMYEL | 98 | 2 | 104 | 7 | 85 | 22 | 134 |
| MULT | 40 | 0 | 0 | 4 | 49 | 13 | 79 |
| Total | 2157 | 40 | 2087 | 216 | 2631 | 437 | 2660 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1971 | 30 | 1565 | 168 | 2045 | 337 | 2051 |
| AFFIL | 135 | 2 | 104 | 15 | 183 | 26 | 158 |
| CCOP/NCORP | 1231 | 19 | 991 | 113 | 1376 | 223 | 1358 |
| Non-SWOG | 1687 | 25 | 1304 | 151 | 1838 | 325 | 1978 |
| Total | 5024 | 76 | 3964 | 447 | 5442 | 911 | 5545 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | S2419 | Renal, adv clear cell, IO +/- Biotx, BIOFRONT | 1 | Y | 22-APR-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| BREAST | A012301 | Breast, Early Stg, Tamoxifen | 1 | E | 13-MAY-26 |
| LUNG | S1933 | NSCLC, Stg II-III, RT + Atezo | 2 | N | 01-MAY-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 15 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 7 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 6 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 6 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 5 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 4 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 3 |
| LYMPH | AHOD2131 | cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy | 2 | 3 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |